Search research articles
Contact Us
Filters
Showing results (41-50 of 171) with videos related to
Page
of 18
Sort By:
Translational Lung Cancer Research
|
June 13, 2022
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
Xiaodong Gu, Wenxian Wang, Wei Wu, et al.
British Journal of Clinical Pharmacology
|
October 10, 2023
Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case report
Rémi Longuespée, Julia Kunz, Margaux Fresnais, et al.
Frontiers in Oncology
|
February 17, 2022
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
Marc A Schneider, Adriana Rozy, Sabine Wrenger, et al.
Frontiers in Oncology
|
May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
Mei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
BMC Cancer
|
June 29, 2021
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial
Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers
Ioannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
Frontiers in Immunology
|
August 29, 2022
Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection
Matias Ruggieri, Nicolás Ducasa, Claudia Juraske, et al.
Journal of Thoracic Disease
|
April 11, 2020
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, et al.
Cancers
|
May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
Sarah Richtmann, Dennis Wilkens, Arne Warth, et al.
Cell Death Discovery
|
April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis
Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 171) with videos related to
Sort By:
Page
of 18
Translational Lung Cancer Research
|
June 13, 2022
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
Xiaodong Gu, Wenxian Wang, Wei Wu, et al.
British Journal of Clinical Pharmacology
|
October 10, 2023
Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case report
Rémi Longuespée, Julia Kunz, Margaux Fresnais, et al.
Frontiers in Oncology
|
February 17, 2022
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
Marc A Schneider, Adriana Rozy, Sabine Wrenger, et al.
Frontiers in Oncology
|
May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
Mei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
BMC Cancer
|
June 29, 2021
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial
Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers
Ioannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
Frontiers in Immunology
|
August 29, 2022
Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection
Matias Ruggieri, Nicolás Ducasa, Claudia Juraske, et al.
Journal of Thoracic Disease
|
April 11, 2020
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, et al.
Cancers
|
May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
Sarah Richtmann, Dennis Wilkens, Arne Warth, et al.
Cell Death Discovery
|
April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis
Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Page
of 18